Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates BOTHELL, Wash., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) provides an update on the clinical development of its oral first-in-class...

ORION BIOTECHNOLOGY WELCOMES NEW MEMBERS OF SCIENTIFIC ADVISORY BOARD Ottawa, Canada, April 13, 2021 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage biotechnology company focused on precision engineering small protein therapeutics, today...

CU Anschutz Medical Campus Enterprise Launches Revolutionary Drug Test That Takes the Guesswork Out of Drug Use and Misuse DENVER, CO--(Marketwired - Jan 7, 2014) - For the first time, treatment providers will be able to see a complete picture of their patients' drug use and misuse using a revolutionary new drug test...

Tranzyme Pharma Secures Additional $9.3 Million Debt Financing RESEARCH TRIANGLE PARK, N.C., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that it received an additional net $9.3 million in term loan proceeds through an amendment...